Gene-eluting stents: Adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis

Molecular Therapy

Volumn 16, Issue 10, 2008, Pages 1674-1680

  Sharif, Faisal ^a,b   Hynes, Sean O ^a   Cooney, Ronan ^a   Howard, Linda ^a   McMahon, Jill ^a   Daly, Kieran ^b   Crowley, James ^b   Barry, Frank ^a   O'Brien, Timothy ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHORYLCHOLINE;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; GENE OVEREXPRESSION; HYPERCHOLESTEROLEMIA; IN-STENT RESTENOSIS; MALE; MORPHOMETRICS; NONHUMAN; POSTOPERATIVE THROMBOSIS; QUANTITATIVE ANALYSIS; RABBIT; RISK REDUCTION; TISSUE REGENERATION; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA;

EID: 54749144683     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.165     Document Type: Article

References (28)

1. Bittl, JA (1996). Advances in coronary angioplasty. N Engl J Med 335: 1290-1302.
2. Morice, MC, Serruys, PW, Sousa, JE, Fajadet, J, Ban Hayashi, E, Perlin, M et al. (2002). A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346: 1773-1780.
3. Sousa, JE, Costa, MA, Sousa, AG, Abizaid, AC, Seixas, AC, Abizaid, AS et al. (2003). Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107: 381-383.
4. Shuchman, M (2007). Debating the risks of drug-eluting stents. N Engl J Med 356: 325-328.
5. Pfisterer, M, Brunner-La Rocca, HP, Buser, PT, Rickenbacher, P Hunziker, P, Mueller, C et al. (2006). Late clinical events after clopiclogrel discontinuation may limit the benefit at drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48: 2584-2591.
6. Iakovou, I, Schmidt, T, Bonizzoni, E, Ge, L, Sangiorgi, GM, Stankovic, G et al. (2005). Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 2126-2130.
7. Sharif, F, Hynes, SO, McMahon, J, Cooney, R, Conroy, S, Dockery, P et al. (2006). Gene-eluting stents: Comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo. Hum Gene Ther 17: 741-750.
8. Van Belle, E, Tio, FO, Chen, D, Maillard, L, Chen, D, Kearney, M et al. (1997). Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 29: 1371-1379.
9. Cooney, R, Hynes, SO, Sharif, F, Howard, L and O'Brien, T (2006). Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther 14: 396-404.
10. Lusis, AJ (2000). Atherosclerosis. Nature 407: 233-241.
11. Vogel, RA (1997). Coronary risk factors, endothelial function, and atherosclerosis: A review. Clin Cardiol 20: 426-432.
12. Kubes, P, Suzuki, M and Granger, DN (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655.
13. Garg, UC and Hassid, A (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777.
14. Kullo, IJ, Mozes, G, Schwartz, RS, Gloviczki, P, Crotty, TB, Barber, DA et al. (1997). Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 96: 2254-2261.
15. Sato, J, Mohacsi, T, Noel, A, Jost C, Gloviczki, P, Mozes, G et al. (2000). In vivo gene transfer of endothelial nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits enhances endothelium-dependent relaxations. Stroke 31: 968-975.
16. Von der Leyen, HE, Gibbons, GH, Morishita, R, Lewis, NP, Zhang, L, Nakajima, M et al. (1995). Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141.
17. Cooney, R, Hynes, SO, Duffy, AM, Sharif, F and O'Brien, T (2006). Adenoviral mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation. J Vasc Res 43: 462-472.
18. Sato, J, Nair, K, Hiddinga, J, Eberhardt, NL, Fitzpatrick, LA, Katusic, ZS et al. (2000). eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res 47: 697-706.
19. Lund, DD, Faraci, FM, Miller, FJ Jr. and Heistad, DD (2000). Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101: 1027-1033.
20. Onoue, H, Tsutsui, M, Smith, L, Stelter, A, O'Brien, T and Katusic, ZS (1998). Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29: 1959-1965.
21. Babaei, S and Stewart, DJ (2002). Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovas Res 55: 190-200.
22. Luczak, K, Balcerczyk, A, Soszynski, M and Bartosz, G (2004). Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 28: 483-486.
23. Zheng, J, Wen, Y, Austin; JL and Chen, DB (2006). Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biol Reprod 74: 375-382.
24. Katusic, ZS, Stelter, A and Milstien, S (1998). Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 18: 27-32.
25. Johnson, TW Wu, YX, Herdeg, C, Baumbach, A, Newby, AC, Karsch, KR et al. (2005). Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler Thromb Vasc Biol 25: 754-759.
26. Walter, DH, Cejna, M, Diaz-Sandoval, L, Willis, S, Kirkwood, L, Stratford, PW et al. (2004). Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: An alternative strategy for inhibition of restenosis. Circulation 110: 36-45.
27. Kullo, IJ, Schwartz, RS, Pompili, VJ, Tsutsui, M, Milstien, S, Fitzpatrick, LA et al. (1997). Expression and function of recombinant endothelial NO synthase in coronary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 2405-2412.
28. Schwartz, RS, Huber, KC, Murphy, JG, Edwards, WD, Camrud, AR, Vlietstra, RE et al. (1992). Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 19: 267-274.